Potential risk factors for vertical HIV-1 transmission in Catalonia, Spain: The protective role of Cesarean section

AIDS

Volumn 11, Issue 15, 1997, Pages 1851-1857

  Maguire, Andrew ^a   Sánchez, Emilia ^b   Fortuny, Claudia ^c   Casabona, Jordi ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b C Agy Hlth Technol Assess Res   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Cesarean section; HIV; Obstetrics; Paediatrics; Spain; Vertical transmission

Indexed keywords

ANTIGEN P24;

ARTICLE; BIRTH WEIGHT; BREAST FEEDING; CESAREAN SECTION; DELIVERY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; PRIORITY JOURNAL; RISK FACTOR; SPAIN; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VERY LOW BIRTH WEIGHT;

EID: 0030727244     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199715000-00010     Document Type: Article

References (38)

1. Peckham C, Gibb D: Mother-to-child transmission of the human immunodeficiency virus. New Engl J Med 1995, 333:298-302.
2. European Collaborative Study: Risk factors for mother-to-child transmission of HIV-1. Lancet 1992, 339:1007-1012.
3. Dickover RE, Garratty EM, Herman SA, et al.: Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 1996, 275:599-605.
4. Frb P, Kräuchi S, Bürgin D, Biedermann K, Camli C, Rudin C: Quantitative anti-p24 determination can predict the risk of vertical transmission. J Acquir Immune Defic Syndr 1994, 7:261-264.
5. Landesman SH, Kalish LA, Burns DN, et al.: Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. New Engl J Med 1996, 334:1617-1623.
6. Kuhn I, Bobat T, Coutsaudis A, et al.: Cesarean deliveries and maternal-infant HIV transmission: results from a prospective study in South Africa. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 11:478-483.
7. Mandelbrot L, Mayaux MJ, Bongain A, et al.: Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. Am J Obstet Gynecol 1996, 175:661-667.
8. Iovo PA, de Martino M, Gabiano C, et al.: Mode of delivery and gestational age influence perinatal HIV-1 transmission. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 11:88-94.
9. The European Collaborative Study: Caesarean section and risk of vertical tranmission of HIV-1 infection. Lancet 1994, 343:1464-1467.
10. Dunn DT, Newell ML, Mayaux MJ, et al.: Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. J Acquir Immune Defic Syndr Hum Retrovirol 1994, 7:1064-1066.
11. Goedert JJ, Duliège AM, Amos CI, Felton S, Biggar RJ: High risk of HIV-1 infection for first-born twins. Lancet 1991, 338:1471-1475.
12. The European Collaborative Study.: Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 1996, 10:1675-1681.
13. Connor EM, Sperling RS, Gelber R, et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New Engl J Med 1994, 331:1173-1180.
14. Ziegler JB, Cooper DA, Johnson RD, Gold J: Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1985, 1:896-898.
15. Lepage P, Van de Perre P, Carael M, et al.: Postnatal transmission of HIV from mother to child. Lancet 1987, ii:400.
16. Weinbreck P, Loustaud V, Denis F, Vidal B, Mounier M, de Lumley L: Postnatal transmission of HIV. Lancet 1988, i:482.
17. Blanche S, Rouzioux C, Guihard Moscato ML, et al.: A prospective study of infants born to women seropositive for human immunodefiency virus type 1. New Engl J Med 1989, 320:1643-1648.
18. Gayle H, Coutinho R: Epidemiology of HIV infection with a focus on mother-to-child transmission and among drug users. Curr Opin Infect Dis 1993, 6:200-204.
19. Coll O, Hernández M, Boucher CAB, et al.: Vertical HIV-1 transmission correlates with a high maternal viral load at delivery. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:26-30.
20. Generalitat de Catalunya. Departament de Sanitat i Seguretat Social: Bull Epidem Catalunya 1996, 17:124-129.
21. Vall Mayans M, Maya A, Matas L, Casabona J: Prevalence of maternal HIV infection in Catalonia, Spain, based on unlinked anonymous testing of newborn babies (1994). Med Clin (Barc) 1997 (in press).
22. Public Health Laboratory Service: Unlinked Anonymous HIV Seroprevalence Monitoring Programme: England and Wales. Data to the End of 1994. London: Department of Health, 1995.
23. Centers for Disease Control: 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994, 43(RR-12):1-10.
24. Dabis F, Msellati P, Dunn D, et al.: Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues. Ghent (Belgium), 17-20 February 1992. AIDS 1993, 7:1139-1148.
25. R Jiménez, J Figueras, Botet F: Neonatología. Procedimientos, diagnóstitos y terapéuticos. 2nd edn. Barcelona: Espax; 1995.
26. Mayaux MJ, Burgard M, Teglas JP, et al.: Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA 1996, 275:606-610.
27. Sánchez E, Casabona J, Fortuny C, Curell N, Martí C: Vertical transmission of HIV: descriptive epidemiology, risk factors and survival (II). Ann Esp Pediatr 1992, 37:367-371 (in Spanish).
28. Sánchez E, Casabona J: Vertical HIV transmission in pregnancy. Lancet 1991, 338:829-830.
29. Generalitat de Catalunya. Departament de Sanitat i Seguretat Social: Analysis of Mortality in Catalonia, 1992. Barcelona: Departament de Sanitat i Seguretat Social; 1995.
30. Fortuny C, Sánchez E, Coll O, Jiménez R: Vertical transmission of human immunodeficiency virus: six years of evolution (1987-1992). Med Clin (Barc) 1996, 107:530-532 (in Spanish).
31. Rodriguez EM, Mofenson LM, Chang B-H, et al.: Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS 1996, 10:273-282.
32. Boyer PJ, Dillon M, Navaie M, et al.: Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA 1994, 271:1925-1930.
33. 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women. AIDS 1993, 7:1475-1479.
34. Generalitat de Catalunya, Department of Health and Social Security: The Health Plan at Your Fingertips. Health Plan for Catalonia 1996-1998. Barcelona: Departament de Sanitat i Seguretat Social; 1997.
35. Goedert JJ, Coté TR: Public health interventions to reduce pediatric AIDS. Am J Public Health 1994, 84:1065-1066.
36. Rouzioux C, Costagliola D, Burgard M, et al.: Estimating timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. Am J Epidemiol 1995, 142:1330-1337.
37. Kind C: Effects of zidovudine prophylaxis and elective cesarean section on vertical HIV transmission. XI International Conference on AIDS. Vancouver, July 1996 [abstract Tu.C.442].
38. Simonds RJ, Roger M: Preventing perinatal HIV infection. How far have we come? JAMA 1996, 275:1514-1551.